in this issue
Chemical Week Magazine :: Business & Finance :: United States/Americas
Novozymes acquires industrial enzyme business from Iogen
8:43 AM MST | February 8, 2013 | â€”Deepti Ramesh
Novozymes says it will acquire Iogen Bio-Products, the industrial enzyme business of Iogen (Ottawa, ON), for C$67.5 million ($67.7 million) and potential earn-out payments of up to C$12.5 million. The deal provides Novozymes with all commercial rights to Iogen Bio-Productsâ€™ existing product portfolio, pipeline, facilities, and know-how. The acquisition does not include the purchase of process technology assets that relate to Iogenâ€™s second-generation biofuels business. The acquisition is expected to be completed by the end of this month. Iogen Bio-Products...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee